Skip to main content
OpenTrials

Clinical trial condition

Monoclonal Gammopathy of Undetermined Significance

Explore clinical trials studying Monoclonal Gammopathy of Undetermined Significance. Study availability and eligibility vary by location and protocol.

82 public trials 19 recruiting studies

Monoclonal Gammopathy of Undetermined Significance trial results

Conditions
Blood Protein Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more
Locations
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack Commack, New York, United States

NCT01237054

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +16 more
Locations
  • National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States
Conditions
Amyloidosis, Blood Protein Disorders, Hematologic Diseases, +16 more
Locations
  • University of California, Irvine Health Chao Family Comprehensive Cancer Center Orange, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States
  • Tufts Medical Center Boston, Massachusetts, United States
Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +28 more
Locations
  • Arizona Clinical Research Center, Inc. / Arizona Oncology Associates, 1825 N Kolb, Tucson, Arizona, United States
  • Pacific Shores Medical Group 1043 Elm Ave, Suite 104 Long Beach, California, United States
  • UCLA Medical Center Hematology / Oncology Division, 10945 Le Conte Ave #2333, Los Angeles, California, United States
  • Collaborative Research Group 2320 S Seacrest Blvd, Suite 202 Boynton Beach, Florida, United States
View all 26 locations